ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Interventional Cardiology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,512Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 28

$707K Total Retail Price of All Prescriptions

Rank: 1 out of 28

893 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 893 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

0% of this provider’s 13,527 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
METOPROLOL TARTRATE 1,335 1,229 1 2
SIMVASTATIN 906 834 2 4
LISINOPRIL 778 716 3 3
PRADAXA 755 728 10 4 22
WARFARIN SODIUM 749 718 5 10
AMIODARONE HCL 699 684 10 6 20
AMLODIPINE BESYLATE 625 576 7 5
LEVOTHYROXINE SODIUM 610 594 8 27
MULTAQ 581 560 10 9 25
PROPAFENONE HCL 552 516 10 10 24
FUROSEMIDE 545 496 11 6
POTASSIUM CHLORIDE 505 454 12 12
SPIRONOLACTONE 379 347 13 14
METOPROLOL SUCCINATE 349 333 14 7
LOSARTAN POTASSIUM 313 313 15 16
HYDROCHLOROTHIAZIDE 292 283 16 26
NITROGLYCERIN PATCH 288 271 17 43
OMEPRAZOLE 230 220 18 30
CARVEDILOL 216 203 19 1
DIGOXIN 198 196 20 19
ISOSORBIDE MONONITRATE ER 192 177 21 11
DIOVAN 153 144 22 35
RAMIPRIL 152 148 23 23
KLOR-CON 10 135 132 24 56
EFFIENT 134 116 25 33
CLOPIDOGREL 134 116 25 9
SOTALOL 130 119 27 31
CLONIDINE HCL 118 107 28 52
PLAVIX 115 88 29 15
PRAVASTATIN SODIUM 112 111 30 13
ENALAPRIL MALEATE 98 87 31 28
FAMOTIDINE 96 96 32 41
ATORVASTATIN CALCIUM 94 64 33 8
CRESTOR 84 71 34 17
BENICAR 82 82 35 62
ATENOLOL 77 65 36 18
KLOR-CON M20 68 67 37 64
NITROSTAT 68 62 37 32
PACERONE 58 58 39 67
BENAZEPRIL HCL 56 50 40 48
METOLAZONE 55 47 41 58
TEKTURNA 54 51 42 68
BUMETANIDE 51 42 43 54
ISOSORBIDE DINITRATE 50 42 44 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.